The Joint Corp.
General ticker "JYNT" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $127.1M (TTM average)
The Joint Corp. follows the US Stock Market performance with the rate: 4.9%.
Estimated limits based on current volatility of 2.2%: low 8.24$, high 8.60$
Factors to consider:
- Total employees count: 202 (-72.6%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Growth execution, Operational and conduct risks, Economic downturns and volatility, Liquidity and credit risks, IT system disruptions
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [8.06$, 15.41$]
- 2026-12-31 to 2027-12-31 estimated range: [8.36$, 15.89$]
Financial Metrics affecting the JYNT estimates:
- Positive: with PPE of -882.7 at the end of fiscal year the price was neutral
- Negative: Operating cash flow per share per price, % of 1.38 <= 2.37
- Positive: -13.52 < Operating profit margin, % of -1.64
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: Industry operating profit margin (median), % of -0.34 <= 0.59
- Negative: 0 < Industry inventory ratio change (median), % of 0
- Positive: Inventory ratio change, % of -0.17 <= 0
- Positive: -0.55 < Return on assets ratio (scaled to [-100,100]) of -0.44
Short-term JYNT quotes
Long-term JYNT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $115.06MM | $51.88MM | $54.89MM |
| Operating Expenses | $117.14MM | $53.64MM | $55.80MM |
| Operating Income | $-2.07MM | $-1.76MM | $-0.91MM |
| Non-Operating Income | $3.71MM | $0.28MM | $0.68MM |
| Income(Loss) | $1.64MM | $-1.47MM | $-0.23MM |
| Taxes | $11.39MM | $0.06MM | $0.04MM |
| Other Income(Loss) | $1.02MM | $-6.99MM | $3.18MM |
| Net Income(Loss)* | $-9.75MM | $-8.53MM | $2.91MM |
| Stockholders Equity | $24.75MM | $17.92MM | $15.05MM |
| Assets | $87.21MM | $80.42MM | $60.97MM |
| Operating Cash Flow | $14.68MM | $9.42MM | $1.84MM |
| Capital expenditure | $5.00MM | $1.19MM | $1.50MM |
| Investing Cash Flow | $-6.19MM | $-0.63MM | $6.27MM |
| Financing Cash Flow | $0.17MM | $-2.00MM | $-9.81MM |
| Earnings Per Share** | $-0.66 | $-0.57 | $0.19 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.